5月12日晚,中国医药(600056)公告,为进一步提升中国医药营销能力和供应链管理能力,拓宽医药、医疗器械、大健康产品渠道发展新路径,创新医药营销模式,打造公司电商运营平台,中国医药拟与新兴集团签署《关于北京金穗科技开发有限责任公司的100%股权转让协议》,以现金3.02亿元收购新兴集团持有的金穗科技100%的股权。完成收购后,金穗科技将成为中国医药全资子公司。据悉,新兴集团系中国医药控股股东...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.